Will FDA approve any mRNA vaccine against any strain of influenza before 2028?
Salud y medicinaOne-Off
Manifold MarketsCerradoSin KYCDatos de resolución verificadosCalibración aceptableEste mercado se resolvió: Yes (93.8%)
Resuelto: 7 oct 2026, 19:39
Resolución verificada por el proveedor
CoinRithm tiene evidencia del ganador y del momento de liquidación respaldada por el proveedor para este mercado.
Resultado Ganador
Yes
A 7 días
—
A 24 horas
—
Aviso de calidad de datosDatos obsoletos
Datos del 8 oct 2026, 9:36 UTC · política pm-quality-4
Cronología de Probabilidad
Yes93.8%
No6.200000000000003%
Ganada
Perdida
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Will FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiReglas
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against any strain of influenza in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
